These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31762945)

  • 1. Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype.
    Dong X; Lin Q; Aihara A; Li Y; Huang CK; Chung W; Tang Q; Chen X; Carlson R; Nadolny C; Gabriel G; Olsen M; Wands JR
    Oncotarget; 2019 Nov; 10(61):6644-6646. PubMed ID: 31762945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.
    Sheng W; Dong M; Chen C; Li Y; Liu Q; Dong Q
    Oncotarget; 2022; 13():182. PubMed ID: 35070082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine.
    Jung DB; Yun M; Kim EO; Kim J; Kim B; Jung JH; Wang E; Mukopadhyay D; Hammond E; Dredge K; Shridhar V; Kim SH
    Oncotarget; 2019 Sep; 10(54):5669. PubMed ID: 31608142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype.
    Dong X; Lin Q; Aihara A; Li Y; Huang CK; Chung W; Tang Q; Chen X; Carlson R; Nadolny C; Gabriel G; Olsen M; Wands JR
    Oncotarget; 2015 Jan; 6(2):1231-48. PubMed ID: 25483102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Endonuclease G promotes mitochondrial genome cleavage and replication.
    Wiehe RS; Gole B; Chatre L; Walther P; Calzia E; Palmer A; Gebhardt JCM; Ricchetti M; Wiesmüller L
    Oncotarget; 2018 Jun; 9(45):27908. PubMed ID: 29963248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.
    Park J; Choi Y; Namkung J; Yi SG; Kim H; Yu J; Kim Y; Kwon MS; Kwon W; Oh DY; Kim SW; Jeong SY; Han W; Lee KE; Heo JS; Park JO; Park JK; Kim SC; Kang CM; Lee WJ; Lee S; Han S; Park T; Jang JY; Kim Y
    Oncotarget; 2018 Jan; 9(4):5514. PubMed ID: 29436532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.
    Sun JH; Zhou TY; Zhang YL; Zhou GH; Nie CH; Zhu TY; Chen SQ; Wang BQ; Ye S; Shen Y; Guo H; Wang WL; Zheng SS
    Oncotarget; 2018 Mar; 9(20):15435. PubMed ID: 29632656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation.
    Yan Y; Hein AL; Etekpo A; Burchett KM; Lin C; Enke CA; Batra SK; Cowan KH; Ouellette MM
    Oncotarget; 2020 Jan; 11(3):304. PubMed ID: 32076492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.
    Arundhathi A; Chuang WH; Chen JK; Wang SE; Shyr YM; Chen JY; Liao WN; Chen HW; Teng YM; Pai CC; Wang CH
    Oncotarget; 2019 Jan; 10(4):558. PubMed ID: 30728905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Upregulation of microRNA-125b by G-CSF promotes metastasis in colorectal cancer.
    Zhang X; Ma X; An H; Xu C; Cao W; Yuan W; Ma J
    Oncotarget; 2020 Jan; 11(1):115. PubMed ID: 32002128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts.
    Visochek L; Atias D; Spektor I; Castiel A; Golan T; Cohen-Armon M
    Oncotarget; 2020 Feb; 11(5):571-572. PubMed ID: 32082490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: CNOT2 promotes degradation of p62/SQSTM1 as a negative regulator in ATG5 dependent autophagy.
    Jeong K; Kwon HY; Jeong MS; Sohn EJ; Kim SH
    Oncotarget; 2019 Sep; 10(53):5571. PubMed ID: 31565191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene.
    Pu Y; Zhao F; Wang H; Cai W; Gao J; Li Y; Cai S
    Oncotarget; 2017 Sep; 8(36):60723. PubMed ID: 28948006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics.
    Yao Q; An Y; Hou W; Cao YN; Yao MF; Ma NN; Hou L; Zhang H; Liu HJ; Zhang B
    Oncotarget; 2020 Aug; 11(32):3102. PubMed ID: 32850013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: HIF-1α:CRAT:miR-144-3p axis dysregulation promotes osteoarthritis chondrocyte apoptosis and VLCFA accumulation.
    Song J; Kang YH; Yoon S; Chun CH; Jin EJ
    Oncotarget; 2019 Jul; 10(44):4609-4610. PubMed ID: 31360308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer.
    Shields S; Conroy E; O'Grady T; McGoldrick A; Connor K; Ward MP; Useckaite Z; Dempsey E; Reilly R; Fan Y; Chubb A; Matallanas DG; Kay EW; O'Connor D; McCann A; Gallagher WM; Coppinger JA
    Oncotarget; 2019 May; 10(33):3144. PubMed ID: 31139326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
    Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
    Oncotarget; 2019 Nov; 10(60):6540. PubMed ID: 31741718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2019 Aug; 10(50):5253. PubMed ID: 31497254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
    Siu MK; Abou-Kheir W; Yin JJ; Chang YS; Barrett B; Suau F; Casey O; Chen WY; Fang L; Hynes P; Hsieh YY; Liu YN; Huang J; Kelly K
    Oncotarget; 2018 Aug; 9(64):32403. PubMed ID: 30190798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis.
    Pei D; Li Y; Liu X; Yan S; Guo X; Xu X; Guo X
    Oncotarget; 2018 Apr; 9(30):21628. PubMed ID: 29765564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.